---
title: Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women
nct_id: NCT03630718
overall_status: COMPLETED
phase: NA
sponsor: Assistance Publique - Hôpitaux de Paris
study_type: INTERVENTIONAL
primary_condition: Liver Cirrhosis, Biliary
countries: France
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03630718.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03630718"
ct_last_update_post_date: 2025-06-25
last_seen_at: "2026-05-12T06:53:13.685Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women

**Official Title:** Randomized Controlled Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With Primary Biliary Cholangitis in Women (CBP-HOPE)

**NCT ID:** [NCT03630718](https://clinicaltrials.gov/study/NCT03630718)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 55
- **Lead Sponsor:** Assistance Publique - Hôpitaux de Paris
- **Collaborators:** University of Paris 5 - Rene Descartes
- **Conditions:** Liver Cirrhosis, Biliary
- **Start Date:** 2019-05-27
- **Completion Date:** 2023-05-22
- **CT.gov Last Update:** 2025-06-25

## Brief Summary

Fatigue is a clinical symptom that has been described as the most disturbing by around 50% of patients with PBC. It has an important impact on patients' quality of life and is associated with an increased mortality risk. To treat fatigue in PBC, only medical treatments have been tested with limited efficacy or serious sides' effects. In other diseases, mostly cancer, psychological interventions showed efficacy on fatigue decrease. Most interventions consist in psychoeducation with: education about fatigue, development of self-care or coping techniques, activity management and learning to balance between activities and rest. Hypnosis, which consists in a body work for psycho-therapeutic use (e.g., through imagination), has also shown promising results. Moreover, psychological intervention efficacy seems to be influenced by patients' characteristics, such as personality. Therefore, the first aim of the present single-center randomized controlled phase 2 trial is to assess the efficacy of a psycho educational intervention and a hypnosis intervention on PBC patients' fatigue to demonstrate that both psychoeducational and hypnosis interventions decrease patient fatigue.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 75 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Women from 18 to 75 years old,
* Diagnosis of primary biliary cholangitis (PBC) according to recognized criteria (EASL 2017),
* Medically stable under treatment with UDCA initiated for at least 6 months, ie medically stable on the basis of liver biological parameters (no increase of more than 20% in bilirubin, ALP and transaminases) and absence of disabling pruritus (permanent and EVA\> 6/10 or scratching lesions),
* Presenting a significant level of fatigue (fatigue score on PBC-40\>= 33),
* Understanding the French language,
* Availability and ability of the patient to access an internet network terminal to answer the online questionnaires of the study,
* Signed consent form.

Exclusion Criteria:

* Presence of cirrhosis with a Child-Pugh B or C,
* Presence of disabling pruritus (permanent, or EVA\>= 7/10 in the last 3 weeks, or objectivable scratching skin lesions),
* Patient on liver transplantation waiting list or total bilirubin\> 50 μmol / L (3 mg / dL), or recent complication (\<6 months) of cirrhosis (ascites, hepatic encephalopathy, rupture bleeding) of esophageal varices),
* Untreated depressive disorder,
* Any comorbidity not medically controlled (i.e. all dosage changes \<3 months due to a control of the associated pathology deemed insufficient by the referring physician) or life-threatening in the medium term (within 2 years).
* Psychiatric disorder modifying the relationship to the reality
```

## Arms

- **Control Group (CG)** (NO_INTERVENTION) — Patients assigned to no intervention
- **Psychoeducational Intervention Group (EG-EDU)** (ACTIVE_COMPARATOR) — Patients assigned to psychoeducational intervention
- **Hypnosis intervention Group (EG-HYP)** (ACTIVE_COMPARATOR) — Patients assigned to hypnosis intervention

## Interventions

- **Psychoeducational Intervention** (BEHAVIORAL) — The psychoeducational intervention will be a structured education programme and will consist of informing patients about fatigue dimensions, aetiology and treatments, by helping them to develop strategies to cope with fatigue better and by teaching them to manage the balance between activities and rest.

The construction of the contents of the sessions of this intervention will aim to reduce fatigue via the programme developed by Reif et al. in cancer patients and is composed of 6 sessions of 90 minutes, one session per week. It is a group intervention for 8 patients. For this project, the investigators have reorganised the sessions and their content to fit with an individual format adapted to PBC. This format is more appropriate to take into account the specificity of the manifestation of fatigue for each patient.
- **Hypnosis intervention** (BEHAVIORAL) — The hypnosis intervention will consist of decreasing fatigue and the related distress, and increasing feelings of energy and well-being.

Therefore, each hypnosis exercise will be audiotaped and given to the patient at the end of the session. Patients will be asked to use these recordings as much as they want to help them to manage fatigue. The techniques used are inspired by those used in chronic pain management and fatigue.

## Primary Outcomes

- **PBC-40 questionaire** _(time frame: At month 3)_

## Secondary Outcomes

- **Short Form Health Survey (SF36) (1)** _(time frame: At Day 0)_
- **Short Form Health Survey (SF36) (2)** _(time frame: At week 5)_
- **Short Form Health Survey (SF36) (3)** _(time frame: At month 3)_
- **Short Form Health Survey (SF36) (4)** _(time frame: At month 6)_
- **Multidimensional fatigue inventory (MFI) (1)** _(time frame: At Day 0)_
- **Multidimensional fatigue inventory (MFI) (2)** _(time frame: At week 5)_
- **Multidimensional fatigue inventory (MFI) (3)** _(time frame: At month 3)_
- **Multidimensional fatigue inventory (MFI) (4)** _(time frame: At month 6)_
- **PBC-40 questionaire (1)** _(time frame: At Day 0)_
- **PBC-40 questionaire (2)** _(time frame: At week 5)_
- **PBC-40 questionaire (3)** _(time frame: At month 6)_
- **Pittsburg Sleep Quality Inventory (PSQI) (1)** _(time frame: At Day 0)_
- **Pittsburg Sleep Quality Inventory (PSQI) (2)** _(time frame: At week 5)_
- **Pittsburg Sleep Quality Inventory (PSQI) (3)** _(time frame: At month 3)_
- **Pittsburg Sleep Quality Inventory (PSQI) (4)** _(time frame: At month 6)_
- **Epworth Sleeping Scale (ESS) (1)** _(time frame: At Day 0)_
- **Epworth Sleeping Scale (ESS) (2)** _(time frame: At week 5)_
- **Epworth Sleeping Scale (ESS) (3)** _(time frame: At month 3)_
- **Epworth Sleeping Scale (ESS) (4)** _(time frame: At month 6)_
- **Hospital Anxiety and Depression Scale (HADS) (1)** _(time frame: At Day 0)_
- **Hospital Anxiety and Depression Scale (HADS) (2)** _(time frame: At week 5)_
- **Hospital Anxiety and Depression Scale (HADS) (3)** _(time frame: At month 3)_
- **Hospital Anxiety and Depression Scale (HADS) (4)** _(time frame: At month 6)_

## Locations (1)

- Service hépatologie Hôpital Saint-Antoine, Paris, France

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.service hépatologie hôpital saint-antoine|paris||france` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03630718.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03630718*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*